H.R. 4395 · 109th Congress
Medicare Prescription Drug Affordability Act of 2005
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
ConyersSponsor5 cosponsors · 5 D
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Medicare Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to revise part D (Voluntary Prescription Drug Benefit Program) as added by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide for: (1) no premium; (2) no deductible; (3) coinsurance at a rate of 10%; (4) a…
What it does: CRS summary · Introduced in House · Nov 18, 2005
Medicare Prescription Drug Affordability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to revise part D (Voluntary Prescription Drug Benefit Program) as added by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to provide for: (1) no premium; (2) no deductible; (3) coinsurance at a rate of 10%; (4) a $1,500 annual limit on out-of-pocket spending on covered drugs; and (5) reduced cost-sharing for lower-income individuals.
Revises the Medigap program and the membership and duties of the Medicare payment advisory commission.
Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug and Cosmetic Act to: (1) repeal certain sections of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 relating to importation of prescription drugs from Canada; and (2) restore previous law, amended to direct the Secretary of Health and Human Services to allow qualifying individuals (in addition to pharmacists and wholesalers) to import covered products.
Repeals the mandate that the Secretary require a foreign seller to specify the original source of the product and the amount of each product lot originally received.
Amends requirements for the testing of imported covered products.
Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.
Establishes a permanent bipartisan Quality Control and Cost Containment Blue Ribbon Task Force.
Repeals the Comparative Cost Adjustment Program and prohibits the application of law in a manner that prevents a Medicare beneficiary from continuing to obtain benefits under a traditional fee-for-service Medicare program.
Amends SSA title XVIII to repeal the Medicare Advantage Regional Plan Stabilization Fund.
Repeals Health Savings Accounts.
Provides for application of risk adjustment reflecting characteristics for the entire Medicare population.
Directs the Secretary to make a specified phased-in adjustment of payment rates to Medicare+Choice payment organizations.
Repeals the Medicare expenditure cap.
Provides for continuous open enrollment in Medicare Advantage Plans.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Prescription Drug Affordability Act of 2005
Latest action (Dec 16, 2005): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Nov 18, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.